Overview
AI-powered multiomics platform for early cancer detection.
Details
Freenome’s blood-based tests use ML on cfDNA, methylation, and proteomics for CRC and other cancer screening.
Freenome
AI-powered multiomics platform for early cancer detection. Freenome's blood-based tests use ML on cfDNA, methylation, and proteomics for CRC and other cancer screening.